Caregen Co., Ltd. (KOSDAQ:214370)
South Korea · Delayed Price · Currency is KRW 115,200
-5,600 (-4.64%)
At close: Feb 6, 2026
Caregen Revenue
Caregen had revenue of 17.09B KRW in the quarter ending September 30, 2025, a decrease of -15.89%. This brings the company's revenue in the last twelve months to 77.86B, down -1.03% year-over-year. In the year 2024, Caregen had annual revenue of 82.59B with 4.26% growth.
Revenue (ttm)
77.86B
Revenue Growth
-1.03%
P/S Ratio
72.31
Revenue / Employee
403.40M
Employees
193
Market Cap
5.63T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82.59B | 3.38B | 4.26% |
| Dec 31, 2023 | 79.21B | 10.11B | 14.63% |
| Dec 31, 2022 | 69.10B | 10.01B | 16.94% |
| Dec 31, 2021 | 59.09B | -1.21B | -2.00% |
| Dec 31, 2020 | 60.30B | -4.40B | -6.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 89.78B |
| Aimed Bio | 29.65B |
| ROKIT Healthcare | 20.33B |
| JS Link | 16.14B |
| AprilBio | 8.97B |
| Qurient | 8.28B |
| AbClon | 3.80B |
| IntoCell | 1.68B |
Caregen News
- 1 year ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 1 year ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn